Sage Journals: Discover world-class research

Open access

Review article

First published 2012

Emerging Pharmacotherapy for Relapsed or Refractory Hodgkins Lymphoma: Focus on Brentuximab Vedotin

Michelle Furtado, Simon Rule

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2012-3

Brentuximab Vedotin: A New Age in the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma

Stephanie S Minich

Annals of Pharmacotherapy

Retricted access

Case report

First published 2022-7

Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphoma

Rosalaura V Villarreal-González, Sandra N González-Díaz, Wendy J Santos-Fernández [...]

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2018-9

Update on the role of brentuximab vedotin in classical Hodgkin lymphoma

Sarah Tomassetti, Alex F. Herrera

Therapeutic Advances in Hematology

Open access

Research article

First published 2026

Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy

Andrew G. Kuang, Malek Shatila, Jay S. Shah [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2012-8

Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma

Christos Vaklavas, Andres Forero-Torres

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2023-4

Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series

Alessandro Broccoli, Lisa Argnani, Paolo Elia Coppola [...]

Tumori Journal

Retricted access

Review article

First published 2025-1

The efficacy and safety of brentuximab vedotin for peripheral T-cell lymphoma: A systemic review and meta-analysis

Jiarun Li, Shuhan Tang, Jinyi Liu [...]

Journal of Investigative Medicine

Retricted access

Research article

First published 2021-10

Brentuximab vedotin in real life,a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma

Lucie Oberic, Faustine Delzor, Caroline Protin [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2021-3

Rapid desensitization to brentuximab vedotin after severe anaphylaxis in the treatment of refractory Hodgkin’s lymphoma

Rosalaura V. Villarreal-Gonzalez, Sandra N. Gonzalez-Diaz, Cindy E. de Lira-Quezada [...]

Journal of Oncology Pharmacy Practice

Search results